Literature DB >> 32635771

Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85.

Fabio Cardinale1, Enrico Lombardi2, Oliviero Rossi3, Diego Bagnasco4, Aldo Bellocchi5, Francesco Menzella6.   

Abstract

INTRODUCTION: Damage to the respiratory epithelium, is often a multifactorial phenomenon. The risk for developing a damage in respiratory epithelium and recurrent respiratory infections may vary among individuals. Preventive measures are based on strengthening the immune function, thus increasing the natural response to pathogens. Immunomodulatory agents are: i. synthetic molecules; ii. Probiotics, prebiotics, symbiotics; iii. Lysates, bacterial extracts immunomodulators: OM-85, RU 41740, D53; iv. Trace elements, vitamins. OM-85 is used for the prevention of recurrent respiratory tract infections and/or exacerbations both in adults and children, showing a good efficacy and safety profile. Its active principle, an extract of bacterial lysates isolated from 21 known respiratory pathogenic strains, shows protection against airway infections of bacterial and viral origin. AREAS COVERED: This non-systematic review focuses on bacterial lysates and in particular on OM-85 and its effects on respiratory epithelium function and activity in asthma respiratory infections. Studies were selected by PubMed search of "bacterial lysate" or "OM-85" and "respiratory epithelium" or "respiratory infections", from 1993 to 2019. EXPERT OPINION: Results highlight the ability of OM-85 to trigger immunomodulatory and protective immune responses against different pathogens in vivo, including influenza and respiratory syncytial virus as well bacterial superinfection following influenza.

Entities:  

Keywords:  Asthma; COPD; OM-85; epithelium; immunomodulation; respiratory infections

Mesh:

Substances:

Year:  2020        PMID: 32635771     DOI: 10.1080/17476348.2020.1793673

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  9 in total

Review 1.  The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.

Authors:  Steve N Georas; Rosalind J Wright; Anastasia Ivanova; Elliot Israel; Lisa M LaVange; Praveen Akuthota; Tara F Carr; Loren C Denlinger; Merritt L Fajt; Rajesh Kumar; Wanda K O'Neal; Wanda Phipatanakul; Stanley J Szefler; Mark A Aronica; Leonard B Bacharier; Allison J Burbank; Mario Castro; Laura Crotty Alexander; Julie Bamdad; Juan Carlos Cardet; Suzy A A Comhair; Ronina A Covar; Emily A DiMango; Kim Erwin; Serpil C Erzurum; John V Fahy; Jonathan M Gaffin; Benjamin Gaston; Lynn B Gerald; Eric A Hoffman; Fernando Holguin; Daniel J Jackson; John James; Nizar N Jarjour; Nicholas J Kenyon; Sumita Khatri; John P Kirwan; Monica Kraft; Jerry A Krishnan; Andrew H Liu; Mark C Liu; M Alison Marquis; Fernando Martinez; Jacob Mey; Wendy C Moore; James N Moy; Victor E Ortega; David B Peden; Emily Pennington; Michael C Peters; Kristie Ross; Maria Sanchez; Lewis J Smith; Ronald L Sorkness; Michael E Wechsler; Sally E Wenzel; Steven R White; Joe Zein; Amir A Zeki; Patricia Noel
Journal:  J Allergy Clin Immunol       Date:  2021-11-29       Impact factor: 14.290

Review 2.  The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Authors:  Seppo Salminen; Maria Carmen Collado; Akihito Endo; Colin Hill; Sarah Lebeer; Eamonn M M Quigley; Mary Ellen Sanders; Raanan Shamir; Jonathan R Swann; Hania Szajewska; Gabriel Vinderola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-04       Impact factor: 73.082

3.  Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection.

Authors:  Manuel Salzmann; Patrick Haider; Christoph Kaun; Mira Brekalo; Boris Hartmann; Theresia Lengheimer; Rebecca Pichler; Thomas Filip; Sophia Derdak; Bruno Podesser; Christian Hengstenberg; Walter S Speidl; Johann Wojta; Roberto Plasenzotti; Philipp J Hohensinner
Journal:  J Innate Immun       Date:  2021-11-12       Impact factor: 7.111

Review 4.  From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine.

Authors:  Laura Maintz; Thomas Bieber; Helen D Simpson; Anne-Laure Demessant-Flavigny
Journal:  J Pers Med       Date:  2022-05-28

5.  Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study.

Authors:  Anna Cantarutti; Elisa Barbieri; Antonio Scamarcia; Luigi Cantarutti; Cristina Canova; Carlo Giaquinto
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

6.  Distinct Antiviral Properties of Two Different Bacterial Lysates.

Authors:  Michael Roth; Hanif J Khameneh; Lei Fang; Michael Tamm; Giovanni A Rossi
Journal:  Can Respir J       Date:  2021-02-04       Impact factor: 2.409

7.  Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis.

Authors:  Changqing Cao; Jinghua Wang; Yuning Li; Yumei Li; Liyan Ma; Mohamed E A Abdelrahim; Yi Zhu
Journal:  Int J Clin Pract       Date:  2021-01-22       Impact factor: 3.149

8.  The role of the microbiome in gastrointestinal inflammation.

Authors:  David J Sanders; Saskia Inniss; Gregory Sebepos-Rogers; Farooq Z Rahman; Andrew M Smith
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming.

Authors:  Emma de Jong; Jean-Francois Lauzon-Joset; Jonatan Leffler; Michael Serralha; Alexander N Larcombe; Claus T Christophersen; Patrick G Holt; Deborah H Strickland; Anthony Bosco
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.